| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 01/31/2012 | US8105830 Polyspecific binding molecules and uses thereof |
| 01/31/2012 | US8105606 Chimeric proteins that induce effects directed against viruses |
| 01/31/2012 | CA2226087C Nucleotide and protein sequences of vertebrate delta genes and methods based thereon |
| 01/26/2012 | WO2011115458A3 Dual antagonist for tnf-α and il-21 for preventing and treating autoimmune diseases |
| 01/26/2012 | WO2011115456A3 Tnf-α and tweak dual antagonist for the prophylaxis and treatment of autoimmune diseases |
| 01/26/2012 | WO2011097527A3 Immunoprotection of therapeutic moieties using enhanced fc regions |
| 01/26/2012 | US20120022236 Recombinant Anti-VLA4 Antibody Molecules |
| 01/26/2012 | US20120022234 Method for the purification of albumin conjugates |
| 01/26/2012 | US20120021967 Synthetic antibodies |
| 01/26/2012 | US20120021450 Methods for magnetic resonance imaging |
| 01/26/2012 | US20120020990 Isolated mammalian monocyte cell genes; related reagents |
| 01/26/2012 | US20120020968 Chimeric DRG11-Responsive (DRAGON) Polypeptides |
| 01/26/2012 | US20120020967 VEGF antibodies comprising modular recognition domains |
| 01/26/2012 | US20120020966 Multispecific antibody targeting and multivalency through modular recognition domains |
| 01/26/2012 | US20120020965 Molecules that bind CD180, compositions and methods of use |
| 01/26/2012 | US20120020890 Staphylococcus aureus proteins and nucleic acids |
| 01/26/2012 | US20120020889 Polypeptides Targeting Vascular Endothelial Growth Factor Receptor-2 and Alpha V Beta 3 Integrin |
| 01/26/2012 | CA2805442A1 Methods and compositions for modification of an hla locus |
| 01/25/2012 | EP2408905A2 Compositions and methods comprising histidyl-trna synthetase splice variants having non-canonical biological activities |
| 01/25/2012 | EP2408814A2 Carrier immunoglobulins and uses thereof |
| 01/25/2012 | EP2408474A2 Compositions and methods for blood-brain barrier delivery of igg-decoy receptor fusion proteins |
| 01/25/2012 | EP1355918B9 Recombinant protective protein from $i(streptococcus pneumoniae) |
| 01/25/2012 | CN102180952B Foot and mouth disease virus antigen polypeptide, fusion antigen polypeptide and vaccine |
| 01/25/2012 | CN101747414B Tumor necrosis factor (TNF)-alpha binding peptide and tumor necrosis factor receptor 1(TNFR1) blocking peptide and applications thereof in treatment of TNF related diseases |
| 01/25/2012 | CN101402687B Fusion protein with high immunogenicity and uses thereof |
| 01/25/2012 | CN101293931B Anti-shrimp white spot syndrome virus recombined bacterium typhosum strain, preparation and uses thereof |
| 01/25/2012 | CN101255197B Fusion protein for serum albumin and interleukin 1 receptor antagonist and uses thereof |
| 01/25/2012 | CN101085813B Soluble TNF acceptor mutant |
| 01/24/2012 | US8101381 Human cytokine receptor |
| 01/24/2012 | US8101181 Antibodies that immunospecifically bind to B lymphocyte stimulator protein |
| 01/24/2012 | CA2462857C Angiotensin peptide-carrier conjugates and uses thereof |
| 01/24/2012 | CA2438935C Supersecretable peptides, processes for their production, and parallel improvement of the secreted form of one or more other polypeptides |
| 01/19/2012 | WO2012009705A1 Ang-2 binding complexes and uses thereof |
| 01/19/2012 | WO2012009648A2 Novel nitrate reductase fusion proteins and uses thereof |
| 01/19/2012 | WO2011112915A3 Methods and compositions containing fc fusiong proteins for enhancing immune responses |
| 01/19/2012 | WO2011112549A3 Temperature sensitive conjugate compositions, and uses related thereto |
| 01/19/2012 | WO2011109106A3 Immunogenic compositions against human progastrin peptides |
| 01/19/2012 | US20120017288 Anticoagulant Fusion Protein Anchored to Cell Membrane |
| 01/19/2012 | US20120015885 COMPOSITIONS AND METHODS FOR CaMKII INHIBITORS AND USES THEREOF |
| 01/19/2012 | US20120015877 Use of gdf traps to increase red blood cell levels |
| 01/19/2012 | US20120015876 Conjugates of glp-1 agonists and uses thereof |
| 01/19/2012 | US20120015432 Isolated bitter taste receptor polypeptides |
| 01/19/2012 | US20120015024 Methods for treating tweak-related conditions |
| 01/19/2012 | US20120014983 recombinant alpha-hemolysin polypeptide of staphylococcus aureus, having a deletion in the stem domain and heterologous sequences inserted |
| 01/19/2012 | US20120014982 Methods and Compositions for Immunizing Against Chlamydia Infection |
| 01/19/2012 | US20120014972 Influenza virus compositions and methods for universal vaccines |
| 01/19/2012 | US20120014957 Dual variable domain immunoglobulins and uses thereof |
| 01/19/2012 | US20120014954 Sparc binding scfvs |
| 01/19/2012 | US20120014952 Complement receptor 2 targeted complement modulators |
| 01/19/2012 | US20120014885 Personal Care Compositions and Methods for Their Use |
| 01/19/2012 | US20120014873 Peptides whose uptake by cells is controllable |
| 01/19/2012 | US20120012823 Color imaging element and method of manufacturing the same, photosensor and method of manufacturing the same, photoelectric transducer and method of manufacturing the same, and electronic device |
| 01/19/2012 | DE102009008252B4 Autokatalytischer Proteinlinker und seine Verwendung zur Herstellung von Fusionsproteinen Autocatalytic protein linker and its use for the production of fusion proteins |
| 01/19/2012 | CA2805408A1 Novel nitrate reductase fusion proteins and uses thereof |
| 01/19/2012 | CA2802207A1 Materials and method for suppressing inflammatory and neuropathic pain |
| 01/18/2012 | EP2407536A1 ADP-ribosyl transferase fusion variant proteins |
| 01/18/2012 | EP2407488A2 Establishment of induced pluripotent stem cell using cell-permeable reprogramming transcription factor for customized stem cell therapy |
| 01/18/2012 | EP2406290A2 Antigen presenting cell targeted cancer vaccines |
| 01/18/2012 | EP2406289A2 Antigen presenting cell targeted anti-viral vaccines |
| 01/18/2012 | EP2406288A2 Antigen presenting cell targeted vaccines |
| 01/18/2012 | EP2406286A2 Anti-cd40 antibodies and uses thereof |
| 01/18/2012 | EP1743940B1 Cardioinhibitory/ antihypertensive novel endogenous physiologically active peptide |
| 01/18/2012 | EP1456385B1 Growth hormone fusion protein |
| 01/18/2012 | EP1456366B1 Novel alkali protease formed by bacillus gibsonii (dsm 14393) and washing and cleaning agents containing said novel alkali protease |
| 01/18/2012 | EP1454138B1 Immunocytokines with modulated selectivity |
| 01/18/2012 | EP1292709B1 Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds |
| 01/18/2012 | CN102325884A Hypo-immunogenic streptavidin and use thereof |
| 01/18/2012 | CN102325882A Protein substance having triple helix structure and manufacturing method therefor |
| 01/18/2012 | CN102325880A Serine protease derivatives and uses in the prevention or the treatment of blood coagulation disorders |
| 01/18/2012 | CN102321658A Mutation method of recombinant protein of pig somatic cells |
| 01/18/2012 | CN102321650A Method for producing fluorescent antibacterial silks from transgenic silkworms |
| 01/18/2012 | CN102321602A Applications of beta-lactamase in improving functional protein folding and preparation of fusion protein |
| 01/18/2012 | CN102321182A Composite antibacterial peptide produced by bacillus natto NT-6 and production method thereof |
| 01/18/2012 | CN102321181A Cyclin D/CDK4 (Cyclin-Dependent Kinase) originated chimeric polypeptide with anti-tumor activity and application as anti-tumor medicament |
| 01/18/2012 | CN102321180A Polypeptide fragment composition and application in preparation of porcine reproductive and respiratory syndrome vaccine thereof |
| 01/18/2012 | CN102321179A Hepatitis C virus recombination protein and gene sequence |
| 01/18/2012 | CN102321178A Novel gonadotropin releasing hormone oriented fusion protein mutant |
| 01/18/2012 | CN102321158A Polypeptide for preventing cell DNA synthesis and inhibiting cell proliferation and application |
| 01/17/2012 | US8097257 MAGE3 polypeptides |
| 01/17/2012 | CA2461917C Isolated dna molecules encoding humanized calcitonin gene-related peptide receptor, related non-human transgenic animals and assay methods |
| 01/17/2012 | CA2451353C Methods and pharmaceutical compositions for immune deception, particularly useful in the treatment of cancer |
| 01/17/2012 | CA2446390C Antigenic epitopes of factor viii, inhibitors directed against said epitopes and use thereof |
| 01/17/2012 | CA2441958C Il-28 polypeptides and polynucleotids |
| 01/17/2012 | CA2264191C Recombinant toxin fragments |
| 01/17/2012 | CA2194478C Gene coding for the e1 endoglucanase |
| 01/12/2012 | WO2012006635A1 Processable single chain molecules and polypeptides made using same |
| 01/12/2012 | WO2012006490A2 Dual variable domain immunoglobulins and uses thereof |
| 01/12/2012 | WO2012006437A2 Polypeptides having antiviral activity and methods for use thereof |
| 01/12/2012 | WO2011090954A3 Engineered opsonin for pathogen detection and treatment |
| 01/12/2012 | US20120010155 Gntiii expression in plants |
| 01/12/2012 | US20120009624 Protein particles |
| 01/12/2012 | US20120009598 T2r, a novel family of taste receptors |
| 01/12/2012 | US20120009579 Monocyte-derived nucleic acids and related compositions and methods |
| 01/12/2012 | US20120009211 Bimer or an oligomer of a dimer, trimer, quadromer or pentamer of recombinant fusion proteins |
| 01/12/2012 | US20120009205 Modified Fc Molecules |
| 01/12/2012 | US20120009190 Identification and method for using the pre-ligand assembly domain of the il-17 receptor |
| 01/12/2012 | CA2804274A1 Factor ix polypeptides and methods of use thereof |
| 01/11/2012 | EP1778729B1 Soluble fusion proteins comprising heterologous polypeptides |
| 01/11/2012 | EP1682583B1 Protein complex using immunoglobulin fragment and method for the preparation thereof |
| 01/11/2012 | EP1483384B1 Method for overexpression of zwitterionic polysaccharides |